2008 ASC Awards

 

November 7-11, 2008

Buena Vista Palace Hotel & Spa
in the Walt Disney World® Resort

Orlando, Florida

 

2008 American Society of Cytopathology Awards

The ASC provides special awards to outstanding individuals in the field of cytology.

The following Awards will be presented throughout the Scientific Sessions of the 56th Annual Scientific Meeting.

 

2008 Papanicolaou Award

The Papanicolaou Award, established in 1958, is the highest award given by the Society and is presented annually to a physician or Ph.D. member.  Recipients are in recognition of meritorious contributions in the field of Cytopathology.

Dr. Celeste N. Powers is the recipient of the 2008 Papanicolaou Award.  Dr. Powers will receive the Papanicolaou Medal and present the Papanicolaou Address on Saturday, November 8, 2008 at 11:30 am, during the Scientific Sessions.

Celeste N. Powers, M.D., Ph.D.

 

2008 Keynote Address

Dr. Douglas R. Lowy will present the Keynote Address during the ASC Annual Scientific Meeting.

Dr. Lowy, from the National Cancer Institute in Bethesda, Maryland, will present his address on “HPV Vaccine: Past, Present and Future.”  Dr. Lowy will receive the Keynote Address Award and present the Keynote Address, during
the Scientific Session, on Saturday, November 8, 2008 at 5:00 pm.

Douglas R. Lowy, M.D., Ph.D.

 

2008 Cytotechnologist Award for Outstanding Achievement

The Cytotechnologist Award for Outstanding Achievement, established in 1969, is presented annually to an ASC Cytotechnologist.  Selection of recipients is in recognition of meritorious service or accomplishments to the field of cytology.

The 2008 Cytotechnologist Award for Outstanding Achievement will be presented to Ms. Donna K. Russell, M. S., SCT(ASCP)HT on Saturday, November 8, 2008 at 11:00 am.

Donna K. Russell, M.S., CT(ASCP)HT

 

2008 Excellence in Education Award

This Award was established in 1998 and is presented annually to a cytotechnologist or physician member of the ASC.  The Award is in recognition of meritorious service or accomplishments in the field of cytopathology education to include the education of cytotechnologists, pathology residents and/or cytopathology fellows.

The 2008 Excellence in Education Award will be presented to Dr. Edmund S. Cibas on Saturday, November 8, 2008 at 11:00 am.

Edmund S. Cibas, M.D.

 

2008 President’s Award

The President’s Award was established in 1992 and is presented annually to an ASC member.  Selection of the recipient is at the discretion of the current ASC President.   The 2008 President’s Award will be presented during the Opening Ceremonies on Saturday, November 8, 2008 at 11:00 am.

 

Poster/Platform Awards

The ASC provides awards to support young investigators submitting abstracts to the ASC Annual Scientific Meeting.  The selection is based upon research excellence as evidenced by peer-reviewed scoring.  Award winners will be announced during the Scientific Sessions on Monday, November 10, 2008 at 5:30 pm.

 

Warren R. Lang, M.D. Resident Physician Award

Established in 1978, the award is presented annually to recognize a resident or fellow in an approved training program who submits the best scientific paper in cytology at a poster or platform session during the ASC Annual Scientific Meeting.

 

Cytotechnologist Scientific Presentation Award

Established in 1969, the award is presented in recognition of a cytotechnologist or student cytotechnologist enrolled in a CAAHEP-accredited cytotechnology program who presents the best scientific paper in cytology at a platform or poster session during the ASC Annual Scientific Meeting.  The first author must be an ASC member.

 

Geno Saccomanno, M.D. New Frontiers in Cytology Award

Established in 1993, the award is presented to an ASC member who is not nominated for another abstract award.  The paper should contribute to better understanding of cell biology or enhanced diagnosis and show significant innovation, good study design and potential diagnostic utility.

 

ASC Foundation – Future of the Profession Award

New this year, this award is presented to either a platform or poster presentation addressing the issues regarding the evolving role of cytopathologists and cytotechnologists in our changing environment.

 

ASC Foundation Awards

The Foundation expands financial support for the ASC mission and its strategic goals of education, advocacy and research.  The following grants or scholarships are supported by the ASC Foundation and will be presented on Saturday, November 8, 2008 at 11:00 am.

 

Cytotechnologist Scholarship

Established in 2002, the Cytotechnologist Scholarship is presented to five qualified cytotechnologists who are ASC members and in their first two years of practice to attend the ASC Annual Scientific Meeting.  This scholarship, based on need and merit, will defray registration, travel and hotel costs.

 

Patient Advocacy Grant

Established by the ASC Advocacy Committee in 2006, the grant is available to ASC members, advocacy patient groups, and neighboring societies. The ASC Foundation awards grants annually for ongoing or new projects for advocacy efforts for patients with gynecologic and other cancers.

Cytopathology Research Seed Award

The ASC Foundation will award $30,000 to a qualified young cytopathology professional (ASC Member) with no more than five years since completion of training, to conduct important research in cytopathology and attend the ASC Annual Scientific Meeting to present his/her data. The goal of this award is to stimulate innovative translational research using material obtained from routine cytology specimens wiht the aim of improving the quality of work done by cytologists, thereby enhancing patient care. This includes (but is not limited to) application of new technologies to cytopathology.

 

ASC Cervical Cytology and HPV Partnership Investigator Award –
A new era of cervical cancer prevention

The ASC Investigator Award is a two-year fellowship award with an annual support of $25,000  each year to fund investigators in the discovery of new knowledge related to cervical cancer screening, and specifically to projects related to the clinical implementation of the new cytological screening technology, HPV vaccine and/or HPV testing.   Projects considered for funding can involve health services or translational research.  Projects that apply existing technologies, procedures, and/or methods in an innovative fashion are encouraged.  Preference will be given to pilot studies that may position the investigator for larger national competitive funding sources.